Jaimee Sharp, 28, is seeking £320,516 to access a specialized brain cancer clinical trial in Ohio. The partner of Mason Gascoigne has already raised over £172,000 to secure more time with her five-year-old son.
The Ohio trial for IDH1-Mutant Astrocytoma
Jaimee Sharp is currently battling an aggressive and incurable form of brain cancer known as IDH1-Mutant, CNS WHO grade 4 Astrocytoma. According to the report, this rare glioma typically carries a median survival rate of approximately five years, even when standard medical interventions are applied. To date, Jaimee Sharp has undergone major brain surgery to remove the tumor,and she is continuing her fight through a regimen of radiotherapy and chemotherapy.
The current glimmer of hope for Jaimee Sharp is a clinical trial located at a hospital in Ohio. This trial involves a new drug specifically designed to target the characteristics of this particular tumor type. While the medical potential is significant,the opportunity is gated by a substantial financial barrier that the family must overcome to ensure she can complete the program.
Racing to raise £320,516 in thirty days
The financial requirement for the treatment is precise and daunting. As reported, the family needs to raise a total of £320,516 to provide Jaimee Sharp with a realistic chance of completing the Ohio-based trial. The urgency is compounded by a strict timeframe; the funds must be gathered within a single month for her to be accepted into the program.
The campaign has seen a rapid surge in support. By Wednesday, the total raised reached £172,257, climbing quickly from an earlier figure of £145,000 . Mason Gascoigne, the adopted son of former England footballer Paul Gascoigne, has been instrumental in driving the appeal. Mason Gascoigne, who was adopted by Paul Gascoigne alongside his sister Bianca, has urged the public to share the appeal widely, noting that even a single pound contribution is deeply appreciated.
The GoFundMe strategy for rare glioma patients
The drive to save Jaimee Sharp reflects a broader, often desperate trend where families turn to public crowdfunding to bridge the gap between standard care and experimental international medicine. For Jaimee Sharp, the primary motivation is her five-year-old son, Teddy. On her GoFundMe page, she expressed a desperate desire to witness more of Teddy's birthdays and Christmas mornings, describing her role as his mother as her entire reason for existence.
This reliance on viral social media appeals highlights the precarious nature of accessing cutting-edge oncology. By sharing raw, personal images of her surgery scars and medical scans on Instagram, Jaimee Sharp has transformed her private medical crisis into a public campaign. This approach leverages the visibility of the Gascoigne family name to attract the thousands of donations necessary to fund a treatment that is otherwise financially inaccessible.
Which Ohio hospital is hosting the trial?
Despite the emotional transparency of the campaign, several critical details remain unverified in the available reporting. The source does not name the specific hospital in Ohio conducting the research, nor does it identify the experimental drug being administered to patients. without these specifics, it is difficult for independent medical observers to assess the trial's phase or its historical success rate for IDH1-Mutant Astrocytoma.
Furthermore,the report focuses exclusively on the family's perspective and the fundraising totals. There has been no statement provided from the medical institution in Ohio regarding the criteria for Jaimee Sharp's acceptance beyond the financial requirement, leaving it unclear if there are other clinical benchmarks she must meet to participate.
Comments 0